Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YR001 ointment in mild to moderate atopic dermatitis
NCT06309355Phase 2Completed
- Sponsor
- Hangzhou Yirui Pharmaceutical Technology Co., Ltd.
- Start
- Jun 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of YR001 in atopic dermatitis (AD), sponsored by Hangzhou Yirui Pharmaceutical Technology Co., Ltd.. Started Jun 2024; status: completed.
02
Drugs
YR001
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06309355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06309355.